About US
Contact us
-
FDA staffers like Sandoz' biosimilarity data for copy of Amgen's EnbrelAmgen ($AMGN) is spending Tuesday making its case for a biosimilar approval before an FDA advisory committee. But come Wednesday, it’ll be Novartis’ ($NVS) Sandoz doing the same with a copy of an Amge2016/7/21
-
Merck KGaA to build $115M Boston hub, aiming for a higher profile in biopharma hotspotBig Pharma is all about beefing up its presence in the Boston area--a hotspot for biotech. And Merck KGaA is the latest to undertake a construction project. Tuesday, the German drugmaker announced it2016/7/20
-
UPDATED: J&J hikes forecast as standouts Imbruvica, Xarelto crank up pharma growthOnce again, Johnson & Johnson’s pharma engine powered top-line growth, with top performers Imbruvica, Xarelto and Daklinza all racking up impressive gains. Thanks to that “notable strength,” the h2016/7/20
-
Patheon Has Made an Initial Public Offering of Ordinary SharesPatheon has made an initial public offering of 30,487,805 of its ordinary shares This figure is added from Patheon selling 25,609,756 ordinary shares and the selling stockholder selling 4,878,049 ord2016/7/19
-
Mesa Labs Acquires Assets of CoaChrom Diagnostica and bioTRADING BeneluxMesa Laboratories' subsidiary Mesa France is acquiring assets and liabilities of two European distributors. These acquisitions involved CoaChrom Diagnostica of Austria and bioTRADING Benelux of the N2016/7/19
-
FDA staffers like Sandoz' biosimilarity data for copy of Amgen's EnbrelAmgen ($AMGN) is spending Tuesday making its case for a biosimilar approval before an FDA advisory committee. But come Wednesday, it’ll be Novartis’ ($NVS) Sandoz doing the same with a copy of an Amge2016/7/18
-
Shire's new dry-eye approval means it's time for an Allergan showdownShire($SHPG) has the approval it’s been waiting for--and the label it wanted, too. Late Monday, the FDA green-lighted dry-eye candidate lifitegrast, to be marketed under the brand name Xiidra. And th2016/7/18
-
FDA grants approval for Pfizer’s Prevnar 13 to prevent pneumococcal pneumoniaAmerican pharmaceutical company Pfizer has received the US Food and Drug Administration (FDA) approval for its Prevnar 13 (pneumococcal 13-valent conjugate vaccine [diphtheria CRM197 protein]) to prev2016/7/15
-
UK NICE denies use of Bristol-Myers’ nivolumab to treat kidney cancerAmerican pharmaceutical company Bristol-Myers Squibb has received a recommendation from the UK National Institute for Health and Care Excellence (NICE) that could deny the use of nivolumab to treat Na2016/7/15
-
Allergan’s Belkyra receives positive opinion from Swedish MPA to treat double chinPharmaceutical company Allergan has received a positive opinion from Sweden's Medical Products Agency (MPA) for Belkyra (deoxycholic acid) to treat moderate to severe convexity related to submental fa2016/7/14